Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
Agency, area, aware, burn, calcium, cGMP, channel, choose, Cmax, commonly, conversion, converted, culminating, CVD, deducting, diagnosed, dosage, enrollment, enzyme, estradiol, estrogen, estrone, evergreen, evidenced, expire, female, formula, function, gastrointestinal, glucose, heart, hold, hormone, host, IL, InClin, inconclusive, interleukin, kidney, linked, mandated, metabolite, mild, million, moderate, modification, normotensive, Nutraceutical, paten, peak, people, placement, ready, relying, remeasured, rendered, repriced, repricing, respiratory, resting, revealed, ROU, sample, separable, stability, throat, twenty, unexpected, unlisted, user, warrant, wash, week, young
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view